Vee J. Gill
- Biotechnology top 0.5%
- Clinical Biochemistry top 1%
- Bacterial Identification and Susceptibility Testing 9
- Infectious Diseases top 2%
- Antimicrobial Resistance in Staphylococcus 4
- HIV/AIDS drug development and treatment 4
- Tuberculosis Research and Epidemiology 4
- Endocrinology top 5%
- Epidemiology top 5%
- Pneumocystis jirovecii pneumonia detection and treatment 8
- Pneumonia and Respiratory Infections 5
- Mycobacterium research and diagnosis 4
-
- Streptococcal Infections and Treatments 5
- Co-authors
- Frida StockPhilip A. PizzoJoseph A. KovacsHenry MasurSteven H. FischerDaniel R. LuceyDouglas J. SchwartzentruberKathleen E. Morton
- Journals
- Journal of Clinical Microbiology (7 papers)Clinical Infectious Diseases (4 papers)The American Journal of Medicine (4 papers)
- Partner nations
- United StatesUnited KingdomDenmark
In The Last Decade
Vee J. Gill
40 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Biotechnology 522
- Clinical Biochemistry 294
- Infectious Diseases 611
- Endocrinology 150
- Epidemiology 879
Countries citing papers authored by Vee J. Gill
This map shows the geographic impact of Vee J. Gill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vee J. Gill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vee J. Gill more than expected).
Fields of papers citing papers by Vee J. Gill
This network shows the impact of papers produced by Vee J. Gill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vee J. Gill. The network helps show where Vee J. Gill may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Vee J. Gill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 38 | |
| 2 | Phase I Study of the Intravenous Administration of AttenuatedSalmonella typhimuriumto Patients With Metastatic Melanomabreakdown → | 2002 | 565 |
| 3 | 2002 | 49 | |
| 4 | 2001 | 68 | |
| 5 | 2001 | 35 | |
| 6 | 2000 | 46 | |
| 7 | 1999 | 271 | |
| 8 | 1999 | 6 | |
| 9 | 1998 | 24 | |
| 10 | 1998 | 52 | |
| 11 | 1997 | 28 | |
| 12 | 1997 | 23 | |
| 13 | 1996 | 9 | |
| 14 | 1995 | 1 | |
| 15 | 1993 | 33 | |
| 16 | 1992 | 33 | |
| 17 | 1991 | 48 | |
| 18 | 1988 | 38 | |
| 19 | 1988 | 20 | |
| 20 | 1988 | 2 |
About Vee J. Gill
Vee J. Gill is a scholar working on Microbiology, Clinical Biochemistry and Endocrinology, having authored 40 papers that have together received 2.1k indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (9 papers), Pneumocystis jirovecii pneumonia detection and treatment (8 papers), Streptococcal Infections and Treatments (5 papers), Pneumonia and Respiratory Infections (5 papers), Antimicrobial Resistance in Staphylococcus (4 papers), Mycobacterium research and diagnosis (4 papers), HIV/AIDS drug development and treatment (4 papers) and Tuberculosis Research and Epidemiology (4 papers). The work is most often cited by research in Biotechnology (522 citations), Clinical Biochemistry (294 citations) and Infectious Diseases (611 citations). Vee J. Gill has collaborated with scholars based in United States, United Kingdom and Denmark. Frequent co-authors include Frida Stock, Philip A. Pizzo, Joseph A. Kovacs, Henry Masur, Steven H. Fischer, Daniel R. Lucey, Douglas J. Schwartzentruber, Kathleen E. Morton, Nicholas P. Restifo and John Mao. Their work appears in journals such as Journal of Clinical Microbiology, Clinical Infectious Diseases, The American Journal of Medicine, Diagnostic Microbiology and Infectious Disease and American Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.